TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2/28/24 19:41 | 2/27/24 | ITCI | Intra-Cellular Therapies, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Van Nostrand Robert L | NY | D | M.d | 371 | 18.56 | 0 | 20 | 10 | D | ||||||||||||||||
2/28/24 19:41 | 2/27/24 | ITCI | Intra-Cellular Therapies, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Van Nostrand Robert L | NY | D | S.d | -1,459 | 72.93 | 0 | -20 | -68 | 10 | D | |||||||||||||||
4/19/23 18:00 | 4/17/23 | ITCI | Intra-Cellular Therapies, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Van Nostrand Robert L | NY | D | M.d | 131 | 13.05 | 0 | 10 | 9 | D | ||||||||||||||||
4/19/23 18:00 | 4/17/23 | ITCI | Intra-Cellular Therapies, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Van Nostrand Robert L | NY | D | S.d | -630 | 63.00 | 0 | -10 | -52 | 9 | D | |||||||||||||||
8/12/22 18:09 | 8/11/22 | ITCI | Intra-Cellular Therapies, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Van Nostrand Robert L | NY | D | M.d | 380 | 12.65 | 0 | 30 | 9 | D | ||||||||||||||||
8/12/22 18:09 | 8/11/22 | ITCI | Intra-Cellular Therapies, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Van Nostrand Robert L | NY | D | S.d | -1,714 | 57.13 | 0 | -30 | -77 | 9 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |